{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:19:30Z","timestamp":1758057570292,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.rce.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:24:15Z","timestamp":1599726255000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Tratamiento de la embolia de pulm\u00f3n. Detecci\u00f3n de la hipertensi\u00f3n pulmonar tromboemb\u00f3lica cr\u00f3nica"],"prefix":"10.1016","volume":"220","author":[{"given":"J.J.","family":"L\u00f3pez-N\u00fa\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2020.07.006_bib0180","first-page":"1","volume":"00","author":"Konstantinides","year":"2019","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rce.2020.07.006_bib0185","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1378\/chest.121.3.877","article-title":"Major pulmonary embolism: Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism","volume":"121","author":"Wood","year":"2002","journal-title":"Chest."},{"key":"10.1016\/j.rce.2020.07.006_bib0190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1538-7836.2012.04698.x","article-title":"Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism","volume":"10","author":"Riera-Mestre","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rce.2020.07.006_bib0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0008-6363(00)00168-1","article-title":"Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: The pivotal role of pulmonary vasoconstriction","volume":"48","author":"Smulders","year":"2000","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.rce.2020.07.006_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.thromres.2013.12.026","article-title":"Lower dosage ofrecombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: A systematic review and meta-analysis","volume":"133","author":"Zhang","year":"2014","journal-title":"Thromb Res."},{"key":"10.1016\/j.rce.2020.07.006_bib0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest."},{"key":"10.1016\/j.rce.2020.07.006_bib0210","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1160\/TH14-12-1036","article-title":"Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants","volume":"113","author":"Hillis","year":"2015","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rce.2020.07.006_bib0215","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2020.07.006_bib0220","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1160\/TH16-02-0137","article-title":"Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin Results from the AMPLIFY trial","volume":"116","author":"Bleker","year":"2016","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rce.2020.07.006_bib0225","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2020.07.006_bib0230","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1160\/TH14-12-1028","article-title":"Anticoagulation strategies for venous thromboembolism: Moving towards a personalised approach","volume":"114","author":"Black","year":"2015","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rce.2020.07.006_bib0235","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1055\/s-0039-1683970","article-title":"Direct oral anticoagulants or standard anticoagulant therapy in fragile patients with venous thromboembolism","volume":"3","author":"L\u00f3pez-N\u00fa\u00f1ez","year":"2019","journal-title":"TH Open."},{"key":"10.1016\/j.rce.2020.07.006_bib0240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.thromres.2020.06.035","article-title":"Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism","volume":"193","author":"Trujillo-Santos","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rce.2020.07.006_bib0245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal \u2014Full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2020.07.006_bib0250","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2020.07.006_bib0255","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rce.2020.07.006_bib0260","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2020.07.006_bib0265","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.thromres.2015.07.011","article-title":"Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants","volume":"136","author":"Posch","year":"2015","journal-title":"Thromb Res."},{"key":"10.1016\/j.rce.2020.07.006_bib0270","unstructured":"The urokinase pulmonary embolism trial. A national cooperative study. Circulation. 1973;47(2 Suppl):II1-108."},{"key":"10.1016\/j.rce.2020.07.006_bib0275","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0735-1097(92)90002-5","article-title":"PAIMS 2 alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism plasminogen activator Italian multicenter study","volume":"20","author":"Dalla-Volta","year":"1992","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rce.2020.07.006_bib0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-8703(97)70108-X","article-title":"Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis","volume":"134","author":"Mikkola","year":"1997","journal-title":"Am Heart J."},{"key":"10.1016\/j.rce.2020.07.006_bib0285","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1378\/chest.111.5.1241","article-title":"Thrombolytic therapy for pulmonary embolism: Frequency of intracranial hemorrhage and associated risk factors","volume":"111","author":"Kanter","year":"1997","journal-title":"Chest."},{"key":"10.1016\/j.rce.2020.07.006_bib0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0036-1597971","article-title":"Catheter-based approaches for the treatment of acute pulmonary embolism","volume":"38","author":"Tapson","year":"2017","journal-title":"Semin Respir Crit Care Med."},{"key":"10.1016\/j.rce.2020.07.006_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.116.004345","article-title":"Interventional treatment of pulmonary embolism","volume":"10","author":"Dudzinski","year":"2017","journal-title":"Circ Cardiovasc Interv."},{"key":"10.1016\/j.rce.2020.07.006_bib0300","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.129.4.1043","article-title":"Management of unsuccessful thrombolysis in acute massive pulmonary embolism","volume":"129","author":"Meneveau","year":"2006","journal-title":"Chest."},{"key":"10.1016\/j.rce.2020.07.006_bib0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11239-018-1737-8","article-title":"Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis","volume":"47","author":"Rosovsky","year":"2019","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.rce.2020.07.006_bib0310","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/bloodadvances.2018017160","article-title":"Risk of recurrent venous thromboembolism according to baseline risk factor profiles","volume":"2","author":"Prins","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.rce.2020.07.006_bib0315","first-page":"30290","article-title":"Predicting risk indices of recurrence in the unprovoked venous thromboembolic disease","volume":"S0025-7753","author":"L\u00f3pez-N\u00fa\u00f1ez","year":"2020","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.rce.2020.07.006_bib0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.amjmed.2016.10.017","article-title":"The clinical course of venous thromboembolism may differ according to cancer site","volume":"130","author":"Mah\u00e9","year":"2017","journal-title":"Am J Med."},{"key":"10.1016\/j.rce.2020.07.006_bib0325","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1378\/chest.130.1.172","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism","volume":"130","author":"Becattini","year":"2006","journal-title":"Chest."},{"key":"10.1016\/j.rce.2020.07.006_bib0330","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2014.07.003","article-title":"The post-PE syndrome: A new concept for chronic complications of pulmonary embolism","volume":"28","author":"Klok","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.rce.2020.07.006_bib0335","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2020.07.006_bib0340","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/rth2.12123","article-title":"Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study","volume":"2","author":"Ma","year":"2018","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.rce.2020.07.006_bib0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rce.2020.07.006_bib0350","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256520302101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256520302101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:40:57Z","timestamp":1757972457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256520302101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":35,"alternative-id":["S0014256520302101"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2020.07.006","relation":{},"ISSN":["0014-2565"],"issn-type":[{"type":"print","value":"0014-2565"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento de la embolia de pulm\u00f3n. Detecci\u00f3n de la hipertensi\u00f3n pulmonar tromboemb\u00f3lica cr\u00f3nica","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights reserved.","name":"copyright","label":"Copyright"}]}}